Suppr超能文献

使用肝硬度测量诊断肝纤维化和肝硬化:FibroScan®M 与 XL 探头的比较。

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®.

机构信息

Centre d'Investigation de la Fibrose Hépatique, Centre Hospitalier Universitaire (CHU) de Bordeaux, Hôpital Haut-Lévêque, France.

出版信息

J Hepatol. 2012 Apr;56(4):833-9. doi: 10.1016/j.jhep.2011.10.017. Epub 2011 Dec 13.

Abstract

BACKGROUND & AIMS: Unreliable results of liver stiffness measurement are obtained in 16% of cases and are independently associated with body mass index (BMI) greater than 30 kg/m(2). A new FibroScan® probe (XL probe) was designed specifically for obese patients. The aim of this study was to evaluate the accuracy of liver stiffness measurement using M and XL probes of Fibroscan® for the diagnosis of fibrosis and cirrhosis in a large cohort of patients.

METHODS

Consecutive patients undergoing liver biopsies for chronic liver disease were prospectively recruited. Liver stiffness measurement was performed within 1 week before liver biopsy using both M and XL probes of FibroScan®.

RESULTS

A total of 286 patients were evaluated. A reliable liver stiffness measurement using M probe was obtained in 79.7% of cases. In the other 21.3%, liver stiffness measurement using XL probe was obtained in 56.9% of patients. A strong correlation was found between M and XL values, regardless of BMI. In all groups, median liver stiffness measurement using the XL probe was significantly lower than liver stiffness measurement using the M probe. By multivariate analysis, unsuccessful liver stiffness examination with M probe was independently associated with age >50 years and BMI >30 kg/m(2). By univariate analysis, only BMI >30 kg/m(2) was associated with unsuccessful liver stiffness measurement with XL probe. No significant difference was observed between the M and XL probes for the diagnosis of liver fibrosis.

CONCLUSIONS

Liver stiffness measurement with either M or XL probe is possible in 91.2% of patients with comparable diagnostic accuracy. In clinical practice, the M probe could be used as first step for liver stiffness measurement. In case of no valid shot or unreliable measurement, the XL probe could be used. This result could be useful for the assessment of liver fibrosis in NAFLD and/or obese patients.

摘要

背景与目的

16%的病例中肝硬度测量结果不可靠,且其独立与体重指数(BMI)大于 30kg/m(2)相关。新的 FibroScan®探头(XL 探头)专为肥胖患者设计。本研究旨在评估 Fibroscan®M 和 XL 探头在诊断大样本患者纤维化和肝硬化中的肝硬度测量的准确性。

方法

连续入组因慢性肝病行肝活检的患者。在肝活检前 1 周内使用 Fibroscan®M 和 XL 探头进行肝硬度测量。

结果

共评估了 286 例患者。M 探头获得可靠肝硬度测量结果的比例为 79.7%。在其余 21.3%的患者中,56.9%的患者使用 XL 探头获得了肝硬度测量结果。无论 BMI 如何,M 和 XL 值之间均存在较强的相关性。在所有组中,XL 探头的中位数肝硬度测量值明显低于 M 探头。多变量分析显示,M 探头肝硬度测量不成功与年龄>50 岁和 BMI>30kg/m(2)独立相关。单变量分析显示,仅 BMI>30kg/m(2)与 XL 探头肝硬度测量不成功相关。M 和 XL 探头在诊断肝纤维化方面无显著差异。

结论

M 或 XL 探头的肝硬度测量在 91.2%的患者中是可行的,且具有相似的诊断准确性。在临床实践中,M 探头可作为肝硬度测量的第一步。如果无法获得有效检测结果或测量结果不可靠,可使用 XL 探头。该结果可能有助于评估非酒精性脂肪性肝病和/或肥胖患者的肝纤维化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验